Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis
Clinical trial NCT05345691 · COMPLETED
Trial details
- NCT number
- NCT05345691
- Sponsor
- Biocon Biologics UK Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2024-06-12
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.